CLA-2-30:S:N:N7:238 810394
Brian S. Goldstein, Esq.
Tompkins & Davidson
One Astor Plaza
1515 Broadway
New York, NY 10036-8901
RE: The tariff classification of "T.R.U.E. TEST" allergen patch
test, from Denmark
Dear Mr. Goldstein:
In your letter dated May 15, 1995, on behalf of your client,
Glaxo Inc. ("Glaxo"), you requested a tariff classification
ruling.
According to your letter, the subject merchandise, "T.R.U.E
TEST" allergen patch test, refers to a thin-layer, rapid-use,
epicutaneous test-system containing 24 of the most common
allergens suspected of causing allergic contact dermatitis. Each
test consists of two pieces of surgical tape containing polyester
patches (twelve per piece) that are coated with a film containing
a uniformly-dispersed, specific allergen or allergen mix. Each
test is covered by a protective sheet, and sealed in a pouch of
laminated foil. The patch test is administered by placing the
two pieces of patch-containing surgical tape on the patient's
back for a minimum of 48 hours. Upon return to the doctor, the
patient is examined for signs of allergic reaction.
The applicable subheading for the subject product will be
3006.30.1000, Harmonized Tariff Schedule of the United States
(HTS), which provides for diagnostic reagents designed to be
administered to the patient: containing antigens or antisera.
The rate of duty will be free.
This merchandise may be subject to the regulations of the
Food and Drug Administration. You may contact them at 5600
Fishers Lane, Rockville, Maryland 20857, telephone number (301)
443-6553.
This ruling is being issued under the provisions of Section
177 of the Customs Regulations (19 C.F.R. 177).
A copy of this ruling letter should be attached to the entry
documents filed at the time this merchandise is imported. If the
documents have been filed without a copy, this ruling should be
brought to the attention of the Customs officer handling the
transaction.
Sincerely,
Jean F. Maguire
Area Director
New York Seaport